Brennan-Olsen SL, Cook S, Leech MT, Bowe SJ, Kowal P, Naidoo N, Ackerman IN, Page RS, Hosking SM, Pasco JA, Mohebbi M. Prevalence of arthritis according to age, sex and socioeconomic status in six low and middle income countries: analysis of data from the World Health Organization study on global AGEing and adult health (SAGE) Wave 1. BMC Musculoskeletal Disorders. 2017 Jun 21;18(1):271. doi:10.1186/s12891-017-1624-z.

Britti D, Crupi R, Impellizzeri D, Gugliandolo E, Fusco R, Schievano C, Morittu VM, Evangelista M, Di Paola R, Cuzzocrea S. A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models. BMC Veterinary Research. 2017 Aug 2;13(1):229. doi:10.1186/s12917-017-1151-z.

Clayton P, Hill M, Bogoda N, Subah S, Venkatesh R. Palmitoylethanolamide: A Natural Compound for Health Management. International Journal of Molecular Sciences. 2021 May 18;22(10):5305. doi: 10.3390/ijms22105305.

Сыров КК, Нестерук BB, inventors; Adam Heller, assigne. Combinations of palmitoylethanolamide for treating chronic pain. Russian Patent RU2701720C1. 2008 [cited 2024 Mar 22].

Felson DT, Niu J, Yang T, Torner J, Lewis CE, Aliabadi P, Sack B, Sharma L, Guermazi A, Goggins J, Nevitt MC; MOST and OAI investigators. Physical activity, alignment and knee osteoarthritis: data from MOST and the OAI. Osteoarthritis and Cartilage. 2013 Jun;21(6):789-795. doi:10.1016/j.joca.2013.03.001.

Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Bramanti P, Piomelli D, Calignano A, Cuzzocrea S. Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. Journal of Pharmacology and Experimental Therapeutics. 2008 Jul 1;326(1):12-23. doi:10.1124/jpet.108.136903.

Healio Rheumatology. RA prevalence in Latin American indigenous community among highest worldwide [Internet]. 2018 [cited 2024 Mar 22].

Impellizzeri D, Esposito E, Di Paola R, Ahmad A, Campolo M, Peli A, Morittu VM, Britti D, Cuzzocrea S. Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. Arthritis Research & Therapy. 2013 Dec;15:1-4. doi:10.1186/ar4382.

Jung JI, Lee HS, Jeon YE, Kim SM, Hong SH, Moon JM, Lim CY, Kim YH, Kim EJ. Anti-inflammatory activity of palmitoylethanolamide ameliorates osteoarthritis induced by monosodium iodoacetate in Sprague-Dawley rats. Inflammopharmacology. 2021 Oct;29(5):1475-1486. doi:10.1007/s10787-021-00870-3.

Keppel Hesselink JM, de Boer T, Witkamp RF. Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold. International Journal of Inflammation. 2013;2013:151028. doi:10.1155/2013/151028.

Oliviero F, Galozzi P, Scanu A, Galuppini F, Lazzarin V, Brocco S, Ravagnan G, Sfriso P, Ramonda R, Spinella P, Punzi L, Pennelli G, Luisetto R. Polydatin Prevents Calcium Pyrophosphate Crystal-Induced Arthritis in Mice. Nutrients. 2021 Mar 13;13(3):929. doi:10.3390/nu13030929.

Rosenthal AK, Ryan LM. Nonpharmacologic and pharmacologic management of CPP crystal arthritis and BCP arthropathy and periarticular syndromesRheumatic Disease Clinics. 2014 May;40(2):343-356. doi:10.1016/j.rdc.2014.01.010.

Rosenfeld S. Majority of osteoarthritis cases from high income countries [Internet]. HCP Live; 2020 [cited 2024 Mar 22].

Oliviero F, Sfriso P, Scanu A, Fiocco U, Spinella P, Punzi L. Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro. Frontiers in Pharmacology. 2013 Apr 17;4:51. doi:10.3389/fphar.2013.00051.

WebMD Editorial Contributors. Foods high in purines [Internet]. WebMD; 2022 [cited 2024 Mar 22]. Available from: https://www.webmd.com/diet/foods-high-in-purines.

Women’s Health & Research Institute of Australia. PEA – Palmitoylethanolamide, a natural painkiller [Internet]. [cited 2024 Mar 22].

Zamudio-Cuevas Y, Oliviero F, Belluzzi E, Scanu A, Andretto L, Galozzi P, Favero M, Ramonda R, Spinella P, Ravagnan G, Lopez-Reyes A. THU0047 Resveratrol and its precursor polydatin inhibit crystal-induced inflammation in vitro by decreasing oxidative stress and il-1beta activation pathway. Annals of Rheumatic Diseases. 2017;76(Suppl 2):216-217. doi:10.1136/annrheumdis-2017-eular.6830.